Budapest, Hungary

Margit Pellioniszne Paroczai


Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1984-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Margit Pellioniszne Paroczai: Innovator in Pharmaceutical Chemistry

Introduction

Margit Pellioniszne Paroczai is a distinguished inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, her work has garnered attention in the scientific community.

Latest Patents

Margit's latest patents include innovative compounds such as 2-methoxyphenylpiperazine derivatives and 3,7-Diazabicyclo [3.3.1] nonanes, which exhibit anti-arrhythmic activity. These new bicyclic compounds are characterized by a general formula where R¹ and R² each represent a C₁-₆ alkyl group. Her research focuses on enhancing the efficacy of treatments for cardiovascular conditions.

Career Highlights

Margit is currently employed at Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. Her role involves extensive research and development, contributing to the advancement of medical science through innovative drug formulations. Her expertise in the field has positioned her as a key figure in her organization.

Collaborations

Margit has collaborated with notable colleagues such as Egon Karpati and Karoly Nador. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment that enhances the quality of their research.

Conclusion

Margit Pellioniszne Paroczai is a remarkable inventor whose work in pharmaceutical chemistry continues to impact the field positively. Her innovative patents and collaborations reflect her dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…